vs
Side-by-side financial comparison of KEMPER Corp (KMPR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
KEMPER Corp is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.0× PERRIGO Co plc). KEMPER Corp runs the higher net margin — -0.7% vs -127.8%, a 127.1% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -4.7%). KEMPER Corp produced more free cash flow last quarter ($166.2M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -0.5%).
Kemper Corporation is an American insurance provider with corporate headquarters located in Chicago, Illinois. With nearly $13 billion in assets, the Kemper family of companies provides insurance to individuals, families, and businesses.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
KMPR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.1B |
| Net Profit | $-8.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | — | -116.0% |
| Net Margin | -0.7% | -127.8% |
| Revenue YoY | -4.7% | -2.5% |
| Net Profit YoY | -108.2% | -3093.9% |
| EPS (diluted) | $-0.03 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.1B |
| Q4 25 | $-8.0M | $-1.4B | ||
| Q3 25 | $-21.0M | $7.5M | ||
| Q2 25 | $72.6M | $-8.4M | ||
| Q1 25 | $99.7M | $-6.4M | ||
| Q4 24 | $97.4M | $-44.4M | ||
| Q3 24 | $73.7M | $-21.0M | ||
| Q2 24 | $75.4M | $-108.4M | ||
| Q1 24 | $71.3M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | — | -116.0% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | 11.2% | 7.4% | ||
| Q2 24 | 10.1% | -2.5% | ||
| Q1 24 | 7.6% | -5.1% |
| Q4 25 | -0.7% | -127.8% | ||
| Q3 25 | -1.7% | 0.7% | ||
| Q2 25 | 5.9% | -0.8% | ||
| Q1 25 | 8.4% | -0.6% | ||
| Q4 24 | 8.2% | -3.9% | ||
| Q3 24 | 6.3% | -1.9% | ||
| Q2 24 | 6.7% | -10.2% | ||
| Q1 24 | 6.2% | 0.2% |
| Q4 25 | $-0.03 | $-10.23 | ||
| Q3 25 | $-0.34 | $0.05 | ||
| Q2 25 | $1.12 | $-0.06 | ||
| Q1 25 | $1.54 | $-0.05 | ||
| Q4 24 | $1.51 | $-0.32 | ||
| Q3 24 | $1.14 | $-0.15 | ||
| Q2 24 | $1.16 | $-0.79 | ||
| Q1 24 | $1.10 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $943.5M | — |
| Stockholders' EquityBook value | $2.7B | $2.9B |
| Total Assets | $12.5B | $8.5B |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $371.2M | $432.1M | ||
| Q2 25 | $407.6M | $454.2M | ||
| Q1 25 | $545.3M | $409.9M | ||
| Q4 24 | $1.0B | $558.8M | ||
| Q3 24 | $696.9M | $1.5B | ||
| Q2 24 | $539.1M | $542.8M | ||
| Q1 24 | $520.7M | $658.5M |
| Q4 25 | $943.5M | — | ||
| Q3 25 | $943.1M | — | ||
| Q2 25 | $942.6M | — | ||
| Q1 25 | $942.1M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.7B | $4.4B | ||
| Q2 25 | $370.0M | $4.5B | ||
| Q1 25 | $366.0M | $4.4B | ||
| Q4 24 | $2.8B | $4.3B | ||
| Q3 24 | $2.8B | $4.6B | ||
| Q2 24 | $358.0M | $4.5B | ||
| Q1 24 | $2.6B | $4.7B |
| Q4 25 | $12.5B | $8.5B | ||
| Q3 25 | $12.4B | $10.1B | ||
| Q2 25 | $12.6B | $10.1B | ||
| Q1 25 | $12.5B | $9.8B | ||
| Q4 24 | $12.6B | $9.6B | ||
| Q3 24 | $12.6B | $11.2B | ||
| Q2 24 | $12.6B | $10.4B | ||
| Q1 24 | $12.6B | $10.6B |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 2.55× | — | ||
| Q1 25 | 2.57× | — | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 3.88× | — | ||
| Q1 24 | 0.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.0M | $175.4M |
| Free Cash FlowOCF − Capex | $166.2M | $148.6M |
| FCF MarginFCF / Revenue | 14.7% | 13.4% |
| Capex IntensityCapex / Revenue | 0.8% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $553.9M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.0M | $175.4M | ||
| Q3 25 | $139.9M | $51.7M | ||
| Q2 25 | $89.6M | $75.9M | ||
| Q1 25 | $180.0M | $-64.5M | ||
| Q4 24 | $175.1M | $312.6M | ||
| Q3 24 | $141.9M | $42.2M | ||
| Q2 24 | $22.9M | $9.5M | ||
| Q1 24 | $43.0M | $-1.4M |
| Q4 25 | $166.2M | $148.6M | ||
| Q3 25 | $133.4M | $29.8M | ||
| Q2 25 | $82.0M | $56.7M | ||
| Q1 25 | $172.3M | $-90.0M | ||
| Q4 24 | $165.4M | $274.9M | ||
| Q3 24 | $131.4M | $15.1M | ||
| Q2 24 | $5.2M | $-18.9M | ||
| Q1 24 | $27.7M | $-26.5M |
| Q4 25 | 14.7% | 13.4% | ||
| Q3 25 | 10.8% | 2.9% | ||
| Q2 25 | 6.7% | 5.4% | ||
| Q1 25 | 14.4% | -8.6% | ||
| Q4 24 | 13.9% | 24.2% | ||
| Q3 24 | 11.1% | 1.4% | ||
| Q2 24 | 0.5% | -1.8% | ||
| Q1 24 | 2.4% | -2.4% |
| Q4 25 | 0.8% | 2.4% | ||
| Q3 25 | 0.5% | 2.1% | ||
| Q2 25 | 0.6% | 1.8% | ||
| Q1 25 | 0.6% | 2.4% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 0.9% | 2.5% | ||
| Q2 24 | 1.6% | 2.7% | ||
| Q1 24 | 1.3% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.81× | — | ||
| Q4 24 | 1.80× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 0.60× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KMPR
| Specialty Property Casualty Insurance Segment | $995.1M | 88% |
| Life Insurance Segment1 | $140.7M | 12% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
